METHODS: In this case-control study, 160 women with preeclampsia and 64 normotensive pregnant controls matched for age and gestational age were enrolled to evaluate the diagnostic utility of urinary TCF21 and its performance alongside angiogenic markers (sFlt-1, PlGF) at the time of clinical presentation for suspected preeclampsia. The gene discussed is PGF; the disease is preeclampsia.